Section Editor: Trevor Flood MD FRCPC
October 23, 2026
Choriocarcinoma is a type of cancer that can start in the testicle. It belongs to a group of cancers called germ cell tumors, which develop from the cells that normally produce sperm. Choriocarcinoma cells look and behave like placental cells. They produce large amounts of a hormone called human chorionic gonadotropin (hCG), which enters the bloodstream.
Choriocarcinoma tends to spread early through the blood, and doctors often find it after it has already spread. Even so, many men with choriocarcinoma are cured with chemotherapy. In the testicle, choriocarcinoma is most often found as a small part of a mixed germ cell tumor rather than on its own.
This article explains what testicular choriocarcinoma is, how the diagnosis is made, and what the findings in a choriocarcinoma pathology report mean. It also explains why the amount of choriocarcinoma and the hCG level matter for the next steps in your care.
Testicular choriocarcinoma most often affects young men between 20 and 40 years old. A tumor made only of choriocarcinoma, called pure choriocarcinoma, is very rare. It makes up fewer than 1 in 100 testicular germ cell tumors. Choriocarcinoma is found as one part of a mixed germ cell tumor in about 7 or 8 in 100 testicular germ cell tumors.
Choriocarcinoma can also develop in women after a pregnancy, starting in the uterus. That disease, called gestational choriocarcinoma, has a different cause and treatment and is not covered in this article.
Testicular choriocarcinoma develops from an early change in the testicle called germ cell neoplasia in situ, or GCNIS. In GCNIS, abnormal germ cells grow inside the seminiferous tubules, the small tubes of the testicle where sperm are made. When these abnormal cells break out of the tubules, they can develop into several types of germ cell tumor, including choriocarcinoma. GCNIS is thought to begin before birth. Factors that increase the risk of a testicular germ cell tumor include:
Many men with choriocarcinoma first notice symptoms caused by spread of the cancer or by the high hCG level, rather than a lump in the testicle. The testicular tumor is often small and may not be felt. Symptoms of testicular choriocarcinoma can include:
The diagnosis of choriocarcinoma usually begins with an ultrasound of the scrotum and blood tests for tumor markers. In choriocarcinoma, the hCG level is usually very high, often more than 50,000 units. When cancer has already spread widely, the care team may start chemotherapy before surgery, based on the hCG level and the scans. The testicle is then removed later.
In most cases, the whole testicle is removed through a cut in the groin in an operation called a radical orchiectomy. A needle biopsy of the testicle is rarely performed. A pathologist then examines the testicle under the microscope.
Choriocarcinoma consists of two kinds of placenta-like cells. Syncytiotrophoblasts are very large cells with many nuclei, and they make hCG. Cytotrophoblasts are smaller cells with a single nucleus. Choriocarcinoma usually contains large areas of bleeding (hemorrhage) and dead tissue (necrosis). Sometimes so much of the tumor has bled or died that only a few tumor cells can be found.
The pathologist checks every part of the tumor for other types of germ cell tumor. When other types are present, the diagnosis is a mixed germ cell tumor, and the report lists choriocarcinoma with its approximate percentage. Imaging such as CT scans of the chest, abdomen, and pelvis checks for spread. Because choriocarcinoma often spreads to the brain, an MRI of the brain is also commonly done.
Immunohistochemistry uses antibodies to show which proteins tumor cells make. In choriocarcinoma, pathologists use immunohistochemistry to confirm the diagnosis and to separate it from other germ cell tumors. The stains used vary between laboratories, but typical results in choriocarcinoma include:
Not every tumor needs all these stains, and when the diagnosis is clear under the microscope, pathologists may use only a few.
Some seminomas and other germ cell tumors contain scattered syncytiotrophoblast cells that make hCG. This is not the same as choriocarcinoma. Choriocarcinoma needs both kinds of placenta-like cells growing together, usually with bleeding. Your report may describe this other finding as seminoma with syncytiotrophoblastic cells, which has a different outlook than choriocarcinoma.
Human chorionic gonadotropin, or hCG, is the most important blood tumor marker for choriocarcinoma. It may also be reported as beta-hCG. Choriocarcinoma makes very large amounts of hCG, so the level is often far higher than with any other testicular tumor. HCG levels are reported in units such as mIU/mL or IU/L, which are equivalent.
Clinicians use the hCG level in three ways. Before treatment, it helps estimate how much cancer is in the body. After surgery or chemotherapy, the level should fall at a steady rate, and a level that stays high suggests cancer remains. During follow-up, a rising hCG is often the first sign that the cancer has come back.
Alpha-fetoprotein (AFP) and lactate dehydrogenase (LDH) are also measured. Choriocarcinoma does not produce AFP, so elevated AFP points to another germ cell tumor type in the same tumor. Our article on tumor markers in your blood test explains these tests in more detail.
When choriocarcinoma is part of a mixed germ cell tumor, your pathology report will list its approximate percentage of the whole tumor. This percentage matters. A small amount of choriocarcinoma, such as 5% or less, does not appear to change the outlook much. A tumor made mostly or entirely of choriocarcinoma is much more likely to have spread and is more difficult to treat.
Unlike many other cancers, choriocarcinoma is not given a histologic grade. Grade describes how different cancer cells look from normal cells, and many other cancers use it to predict behavior. For choriocarcinoma, the amount of choriocarcinoma, hCG level, and stage provide more useful information. Your choriocarcinoma pathology report will not include a grade, as expected.
The pathologist measures the tumor in the removed testicle and reports its greatest dimension in centimeters. Testicular choriocarcinoma is often small, even when it has spread widely. For choriocarcinoma and other nonseminomas, size does not change the tumor stage.
Tumor extension describes how far the choriocarcinoma has grown beyond the testicle. The pathologist examines the nearby tissues to see whether tumor cells have reached any of these structures:
Growth into any structure except the rete testis increases the tumor stage (pT). Growth into the tunica albuginea, the tough capsule directly around the testicle, does not raise the stage on its own.
Lymphovascular invasion means choriocarcinoma cells were seen inside a blood vessel or lymphatic channel. Choriocarcinoma cells naturally grow into blood vessels, which is why this cancer spreads so early through the blood. Your report will describe lymphovascular invasion as present, not identified, or cannot be determined. Lymphovascular invasion changes the stage, because a tumor limited to the testicle is pT1 without it but pT2 with it.
Germ cell neoplasia in situ, or GCNIS, is the early change from which testicular choriocarcinoma and most other adult testicular germ cell tumors develop. In GCNIS, abnormal germ cells line the seminiferous tubules but have not invaded the surrounding tissue. GCNIS may be found in the testicle next to choriocarcinoma. This is an expected finding and does not change the stage, because the invasive tumor already sets the stage.
Sometimes a choriocarcinoma in the testicle bleeds, dies, and shrinks until only a scar remains, in a process called regression. This happens more often with choriocarcinoma than with other germ cell tumors. Your report may describe a scar, fibrosis, or a regressed germ cell tumor. The pathologist makes this diagnosis when the scar contains GCNIS or coarse calcifications inside the tubules. A regressed tumor shows that a cancer found elsewhere in the body most likely started in the testicle.
A margin is the cut edge of tissue removed during surgery. After a radical orchiectomy, the most important margin is the end of the spermatic cord, which is the last tissue cut by the surgeon. Your report will describe the margins in one of these ways:
Lymph nodes are small immune organs found throughout the body. Testicular germ cell tumors usually spread first to the retroperitoneal lymph nodes at the back of the abdomen. Choriocarcinoma can also skip these nodes and spread directly through the bloodstream to the lungs, liver, or brain. Lymph nodes are not removed during a radical orchiectomy, so most orchiectomy reports do not include any.
Lymph nodes may be removed in a later operation, most often after chemotherapy. When they are, the pathologist reports how many nodes contained cancer, the size of the largest involved node or mass, and the types of germ cell tumor present. The report also notes whether extranodal extension is present, meaning cancer cells have broken through the lymph node’s outer capsule.
The pathologic stage of choriocarcinoma is based on the tumor in the removed testicle (pT) and any lymph nodes examined (pN). It uses the TNM staging system in the 8th edition of the AJCC Cancer Staging Manual, which the current CAP testis protocol uses. Imaging, not the pathologist, determines spread to distant organs (M).
The overall stage group does not match the pathologic stage in your report. Your care team assigns the stage group by combining the pathology findings, the scans, and the blood tumor markers. The markers are given an S category from S0 to S3. An hCG level above 50,000 mIU/mL after surgery is S3, which places the cancer in stage III even if the scans show no spread.
The prognosis for testicular choriocarcinoma depends mainly on how much of the tumor is choriocarcinoma, the hCG level, and where the cancer has spread. When choriocarcinoma is only a small part of a mixed germ cell tumor, the outlook is similar to that of other nonseminomas, and most men are cured.
Pure choriocarcinoma, or a tumor made mostly of choriocarcinoma, has a more serious outlook. Nearly all of these men have spread of the cancer at diagnosis, most often to the lungs and liver, and sometimes to the brain. An international system called IGCCCG, updated in 2021, places men with very high hCG levels in its poor prognosis group. About 67 in 100 men in this group are alive five years later, and about 33 in 100 are not. In older studies of pure or mostly choriocarcinoma, outcomes were lower than this, though treatment has improved over time.
Pathologic and laboratory features linked with a higher chance of the cancer spreading or coming back include:
After testicular choriocarcinoma is diagnosed, the next steps depend on the hCG level, the scans, and the percentage of choriocarcinoma in the tumor. Treatment often needs to start quickly. A team plans care, including a medical oncologist experienced in germ cell tumors and a urologist, often at a specialized center.
For choriocarcinoma that has spread, treatment usually involves chemotherapy combinations that include cisplatin, with the amount guided by the IGCCCG prognosis group. When the hCG level is very high and the cancer has spread to the lungs, the care team watches closely during the first cycle of chemotherapy. Tumors with many blood vessels can bleed as they shrink, a rare but serious problem called choriocarcinoma syndrome. When the cancer has spread to the brain, surgery or radiation to the brain may also be considered.
Doctors often check hCG levels during and after treatment because they show how well the treatment is working. Surgery may remove any mass that remains after chemotherapy. For the rare choriocarcinoma that is limited to the testicle with normal markers after surgery, the options may include surveillance, chemotherapy, or lymph node surgery.
Chemotherapy can affect fertility, so sperm banking is usually discussed before treatment when there is time to do it safely. Follow-up visits continue for several years and include hCG blood tests, scans, and checks of testosterone and of the remaining testicle.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name